Is CLOV stock a Buy, Sell, or Hold?

Based on our analysis, CLOV is currently a WAIT with low confidence. 📊 MIXED SIGNALS: CLOV shows conflicting indicators. Wait for confirmation before entering.

What is the fair value of CLOV stock?

Our analysis estimates the fair value range for CLOV to be between $2.97 and $3.87. The current price is $3.89.

What is the analyst price target for CLOV?

The average Wall Street analyst price target for CLOV is $2.82. This implies a potential upside of -26.5% from current levels.

CLOV Stock Analysis: Buy, Sell, or Hold?

CLOV - Clover Health Investments, Corp

HOSPITAL & MEDICAL SERVICE PLANS

$3.89

0.06 (1.57%) ▲

5d: -0.77%

30d: +37.94%

90d: +94.5%

WAIT

LOW Confidence

Protect Your CLOV Gains

Analysis Updated: Jun 5, 2026 12:00 AM ET

Earnings: Aug 04, 2026

Smart Money Distribution

None View Scanner →

Strength: 6.1/10

Get Alerted When CLOV Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 MIXED SIGNALS: CLOV shows conflicting indicators. Wait for confirmation before entering.

See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: CLOV is currently trading at $3.89, which is considered extended relative to its 30-day fair value range of $2.97 to $3.87. From a valuation perspective, the stock is trading at a premium (Forward PE: 38.3) compared to its historical average (33.2). At these levels, the market is pricing in 4.9% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, CLOV is in a uptrend. Immediate support is located at $3.45, while resistance sits at $4.23.

Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $2.82. Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position EXTENDED

Historical Trading Range $2.97 - $3.87

Company Quality Score 57/100 (HOLD)

Volume Confirmation HIGH

Confidence Score 40.5%

Protect Your Profits

Holding CLOV? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

BEARISH: Price extended above range
NEUTRAL: Mixed technical signals (55/100)
BULLISH: High volume confirmation
BEARISH: Trading 26.5% above Wall St target ($2.82)
NEUTRAL: Trading at premium valuation - market expects 4.9% growth which is achievable

Trading Range Analysis

30-Day Trading Range $2.97 - $3.87

Current vs Trading Range EXTENDED

Support & Resistance Levels

Support Level $3.45

Resistance Level $4.23

Current Trend Uptrend

Technical data as of Jun 5, 2026

Fundamental Context

Forward P/E (Next Year Est.) 38.30

Wall Street Target $2.82 (-26.5%)

Revenue Growth (YoY) 62.0%

Profit Margin -2.6%

Valuation Premium vs History +4.9% premium

PE vs Historical 38.3 vs 33.2 STRETCHED

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): +4.9% (market-implied from PE analysis)

1-Year Target $4.02 (+5%)

2-Year Target $4.21 (+10%)

3-Year Target $4.42 (+15%)

3-Yr Target (if PE normalizes) (PE: 38→33) PE COMPRESSION $3.83 (+0%)

Earnings growth offset by PE compression

3-Year Scenarios Using analyst projected EPS growth

Bull: (PE: 38.3, Growth: 11.1%) $5.25 (+37%)

Base: (SPY PE: 21.9, Growth: 11.1%) $3.01 (-22%)

Bear: (PE: 18.6, Growth: 11.1%) $2.55 (-33%)

Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit

bloggers & journalists: you are free to use our charts with attribution.

Last updated: June 08, 2026 12:48 PM ET
Data refreshes hourly during market hours. Next update: 1:48 PM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is CLOV showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

INSIDERS SELLING

Recent Transactions

Brady Patrick Priest SELL 175000 shares 2026-03-04

View Insider Activity Scanner

Unlock Insider Activity

See real-time buying/selling by company executives for CLOV.

Create Free Account

Already have an account? Log In

Top Rated Healthcare Plans Stocks

Top-rated stocks in Healthcare Plans by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
CVS CVS Health Corp	STRONG BUY 28 analysts	$103	64 BUY
UNH UnitedHealth Group Incor…	STRONG BUY 27 analysts	$405	59 HOLD
CI Cigna Corp	STRONG BUY 25 analysts	$341	56 HOLD
ELV Elevance Health Inc	STRONG BUY 22 analysts	$411	57 HOLD
HUM Humana Inc	HOLD 26 analysts	$290	58 HOLD

CVS CVS Health Corp

64 BUY

UNH UnitedHealth Grou…

59 HOLD

CI Cigna Corp

56 HOLD

ELV Elevance Health I…

57 HOLD

HUM Humana Inc

58 HOLD

Advanced CLOV Option Strategies

Professional options setups generated by AI based on today's CLOV price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for CLOV

CLOV Technical Chart CLOV Price Prediction CLOV Earnings Date CLOV Investment Advisor CLOV Fair Price Analyzer CLOV Options Advisor CLOV Options Chain CLOV Options Analysis CLOV Competitors

Compare CLOV with Peers

CLOV vs SKLZ
Which one to buy?

CLOV vs FUBO
Which one to buy?

CLOV vs SNDL
Which one to buy?

CLOV vs BB
Which one to buy?

CLOV vs WKHS
Which one to buy?

Create New Comparison View All Competitors

Tradestie